{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:16:38Z","timestamp":1792786598770,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region \u00d6sterg\u00f6tland","id":[{"id":"https:\/\/ror.org\/024emf479","id-type":"ROR","asserted-by":"crossref"}]},{"name":"King Gustaf V's 80-year Anniversary Foundation"},{"name":"King Gustaf V and Queen Victoria's Freemasons Foundation"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011327","name":"Sandwell and West Birmingham Hospitals NHS Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust Birmingham Clinical Research Facility","id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["8UL1TR000150"],"award-info":[{"award-number":["8UL1TR000150"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UL-1RR-025741"],"award-info":[{"award-number":["UL-1RR-025741"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K24-AR-02318"],"award-info":[{"award-number":["K24-AR-02318"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P60AR064464"],"award-info":[{"award-number":["P60AR064464"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P60-AR-48098"],"award-info":[{"award-number":["P60-AR-48098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017M3A9B4050335"],"award-info":[{"award-number":["NRF-2017M3A9B4050335"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaut.2019.102340","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:15:24Z","timestamp":1571271324000},"page":"102340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus"],"prefix":"10.1016","volume":"106","author":[{"given":"Helena","family":"Enocsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wirestam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Dahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Padyukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"J\u00f6nsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray B.","family":"Urowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna D.","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Romero-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Cheol","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sanchez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Bernatsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Hanly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Isenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan T.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Ginzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela S.","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Winn","family":"Chatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Aranow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meggan","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anne","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Manzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Ramsey-Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Nived","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristjan","family":"Steinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad A.","family":"Zoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Ruiz-Irastorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Sam","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Kalunian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Inanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald F.","family":"van Vollenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Peschken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Askanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian N.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Wetter\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sj\u00f6wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.102340_bib1","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2013-205171","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort","volume":"74","author":"Bruce","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102340_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/096120301670679959","article-title":"Early damage as measured by the SLICC\/ACR damage index is a predictor of mortality in systemic lupus erythematosus","volume":"10","author":"Rahman","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2019.102340_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102340_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.autrev.2016.07.033","article-title":"Pitfalls in lupus","volume":"15","author":"Schneider","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2019.102340_bib5","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/art.25042","article-title":"Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?","volume":"60","author":"Enocsson","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102340_bib6","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/art.38408","article-title":"Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-alpha and a C-reactive protein gene variant","volume":"66","author":"Enocsson","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102340_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semarthrit.2007.09.005","article-title":"High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus","volume":"38","author":"Lee","year":"2008","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102340_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.trsl.2013.07.003","article-title":"Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus","volume":"162","author":"Enocsson","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.jaut.2019.102340_bib9","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1002\/art.34672","article-title":"Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102340_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3899\/jrheum.180713","article-title":"Osteopontin and disease activity in patients with recent-onset systemic lupus erythematosus: results from the SLICC inception cohort","volume":"46","author":"Wirestam","year":"2019","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102340_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thuno","year":"2009","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jaut.2019.102340_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of cell signalling by uPAR","volume":"11","author":"Smith","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2019.102340_bib13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2009-05-220657","article-title":"Efferocytosis: another function of uPAR","volume":"114","author":"Blasi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2019.102340_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCRESAHA.109.213629","article-title":"Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA\/Ro-bound apoptotic cardiocytes: implications in the pathogenesis of congenital heart block","volume":"107","author":"Briassouli","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.jaut.2019.102340_bib15","doi-asserted-by":"crossref","first-page":"17030","DOI":"10.1074\/jbc.M109.010066","article-title":"The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells","volume":"284","author":"D'Mello","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102340_bib16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102340_bib17","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.V91.7.2305","article-title":"Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes","volume":"91","author":"Chavakis","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2019.102340_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/excr.1996.0144","article-title":"The urokinase receptor is a major vitronectin-binding protein on endothelial cells","volume":"224","author":"Kanse","year":"1996","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jaut.2019.102340_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajcp\/102.6.835","article-title":"Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue","volume":"102","author":"Plesner","year":"1994","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2019.102340_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1083\/jcb.100.1.86","article-title":"A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase","volume":"100","author":"Vassalli","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jaut.2019.102340_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","article-title":"Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy","volume":"80","author":"Andersen","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jaut.2019.102340_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13054-018-1943-y","article-title":"Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study","volume":"22","author":"Luo","year":"2018","journal-title":"Crit. Care"},{"key":"10.1016\/j.jaut.2019.102340_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/172460080101600402","article-title":"Soluble urokinase plasminogen activator receptor measurements: influence of sample handling","volume":"16","author":"Riisbro","year":"2001","journal-title":"Int. J. Biol. Mark."},{"key":"10.1016\/j.jaut.2019.102340_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-7-134","article-title":"The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms","volume":"7","author":"Schneider","year":"2007","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102340_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/emermed-2015-205444","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study","volume":"33","author":"Rasmussen","year":"2016","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.jaut.2019.102340_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.58.8.488","article-title":"Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis","volume":"58","author":"Slot","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102340_bib27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.trsl.2014.09.007","article-title":"Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease","volume":"165","author":"Sj\u00f6wall","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.jaut.2019.102340_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MCG.0b013e31822da19d","article-title":"Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection","volume":"46","author":"Berres","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2019.102340_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2011.01.049","article-title":"Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events","volume":"216","author":"Sehestedt","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaut.2019.102340_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cca.2015.02.031","article-title":"Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?","volume":"444","author":"Enocsson","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2019.102340_bib31","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/annrheumdis-2012-202106","article-title":"Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort","volume":"72","author":"Parker","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102340_bib32","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102340_bib33","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102340_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102340_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/ard.62.9.835","article-title":"Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases","volume":"62","author":"Stolt","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102340_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2019.102340_bib37","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2215\/CJN.01640309","article-title":"Measurement and estimation of GFR in children and adolescents","volume":"4","author":"Schwartz","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2019.102340_bib38","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3899\/jrheum.140677","article-title":"Four anti-dsDNA antibody assays in relation to systemic lupus erythematosus disease specificity and activity","volume":"42","author":"Enocsson","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102340_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4137\/BMI.S19876","article-title":"Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population","volume":"9","author":"Haupt","year":"2014","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.jaut.2019.102340_bib40","first-page":"1398","article-title":"High predictive value of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for survival in systemic lupus erythematosus","volume":"29","author":"Nived","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102340_bib41","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.ijcard.2012.07.018","article-title":"Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score","volume":"167","author":"Lyngbaek","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2019.102340_bib42","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102340_bib43","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/liv.12512","article-title":"Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure","volume":"34","author":"Koch","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.jaut.2019.102340_bib44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/cclm-2012-0221","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission","volume":"51","author":"Toldi","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jaut.2019.102340_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-009-9152-0","article-title":"Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis","volume":"33","author":"Pliyev","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.jaut.2019.102340_bib46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2019.102340_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058506","article-title":"NT-proBNP, C-reactive protein and soluble uPAR in a bi-ethnic male population: the SAfrEIC study","volume":"8","author":"Kruger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102340_bib48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2008-12-193524","article-title":"Participation of the urokinase receptor in neutrophil efferocytosis","volume":"114","author":"Park","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2019.102340_bib49","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.4049\/jimmunol.1302590","article-title":"High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis","volume":"192","author":"Yang","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.102340_bib50","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/rheumatology\/ket156","article-title":"A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies","volume":"52","author":"Briassouli","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2019.102340_bib51","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.4049\/jimmunol.1101288","article-title":"Binding of anti-SSA antibodies to apoptotic fetal cardiocytes stimulates urokinase plasminogen activator (uPA)\/uPA receptor-dependent activation of TGF-beta and potentiates fibrosis","volume":"187","author":"Briassouli","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.102340_bib52","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2013-205139","article-title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international task force","volume":"73","author":"van Vollenhoven","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102340_bib53","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3899\/jrheum.150379","article-title":"Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence","volume":"42","author":"Durcan","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102340_bib54","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12891-015-0621-3","article-title":"Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus","volume":"16","author":"Bj\u00f6rk","year":"2015","journal-title":"BMC Muscoskelet. Disord."},{"key":"10.1016\/j.jaut.2019.102340_bib55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/rheumatology\/keg481","article-title":"Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage","volume":"43","author":"Alarcon","year":"2004","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119305554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119305554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:23:22Z","timestamp":1760257402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119305554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":55,"alternative-id":["S0896841119305554"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102340","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102340"}}